Biosensors fends off Angiotech, Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Production and distribution of the Axxion drug-eluting stent continues in Europe after Biosensors prevails in a patent dispute brought by Angiotech and Boston Scientific. Biosensors' stent originally was cleared for sale in Europe in July 2005, but the firm was sued in December 2005. Angiotech and Boston Scientific claimed the device infringed a patent describing the use of paclitaxel and a polymeric coating on a stent. The news could be heartening to stent manufacturer Conor Medsystems, which is also embroiled in litigation in the Netherlands against Angiotech and Boston Scientific over the same patent (1"The Gray Sheet" Feb. 7, 2005, p. 7)...